Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea

ObjectiveTo compare the incidence and survival rates of primary ovarian clear cell carcinoma (OCCC) and ovarian serous carcinoma (OSC) from a nationwide collected database.MethodsWe extracted information of patients with primary OCCC and OSC from the Korea Central Cancer Registry recorded between 19...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Se Ik Kim, Hyeong In Ha, Kyung Jin Eoh, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
Natura:	Articolo
Lingua:	English
Pubblicazione:	Frontiers Media S.A. 2022-04-01
Serie:	Frontiers in Oncology
Soggetti:	ovarian cancer histologic subtype clear cell carcinoma serous carcinoma incidence survival
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2022.874037/full

Documenti analoghi

FREQUENCY OF NAPSIN A POSITIVITY IN OVARIAN CLEAR CELL CARCINOMA AND SEROUS CARCINOMA
di: Zara Saeed, et al.
Pubblicazione: (2018-08-01)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
di: Huimei Zhou, et al.
Pubblicazione: (2020-04-01)

Testicular serous carcinoma of ovarian epithelial type
di: Chang-Hong Yeh, et al.
Pubblicazione: (2017-06-01)

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
di: Kosuke Kanno, et al.
Pubblicazione: (2024-08-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
di: Maho Shimizu, et al.
Pubblicazione: (2021-06-01)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
di: Manon Lefebvre, et al.
Pubblicazione: (2023-01-01)

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
di: Jung Mi Byun, et al.
Pubblicazione: (2023-01-01)

Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database
di: Xiaoduo Li, et al.
Pubblicazione: (2021-02-01)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
di: Ruifen Dong, et al.
Pubblicazione: (2016-09-01)

Nomograms of Combining MRI Multisequences Radiomics and Clinical Factors for Differentiating High-Grade From Low-Grade Serous Ovarian Carcinoma
di: Cuiping Li, et al.
Pubblicazione: (2022-06-01)

Primary ovarian serous carcinomas with extensive squamous differentiation: a case report and literature review
di: Yao Sun, et al.
Pubblicazione: (2021-05-01)

Treatment results and prognostic factors of clear cell ovarian carcinomas and ovarian carcinomas with clear cell component
di: M. D. Ahmedova, et al.
Pubblicazione: (2014-07-01)

Acute Presentation of Large Size Clear Cell Ovarian Carcinoma as Double Torsed Ovarian Tumor
di: Diana Bužinskienė, et al.
Pubblicazione: (2022-01-01)

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin
di: Akira Nishijima, et al.
Pubblicazione: (2024-08-01)

Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
di: Eun-Gyeong Lee, et al.
Pubblicazione: (2023-09-01)

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
di: Hyeong In Ha, et al.
Pubblicazione: (2021-09-01)

Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas
di: Huann-Cheng Horng, et al.
Pubblicazione: (2014-12-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
di: Patricia Martini Diniz, et al.
Pubblicazione: (2011-01-01)

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry
di: Hyeong In Ha, et al.
Pubblicazione: (2022-07-01)

Immunoexpression of p53 and p16 in Low and High-grade Serous Ovarian Cancer: A Cross-sectional Study
di: Ranajit Mandal, et al.
Pubblicazione: (2023-11-01)

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
di: Ling Zhou, et al.
Pubblicazione: (2021-05-01)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
di: Li Jie, et al.
Pubblicazione: (2012-03-01)

Ovarian clear cell carcinoma with bilateral breast metastasis
di: Aashita, et al.
Pubblicazione: (2023-01-01)

A Rare Case of Serous Papillary Ovarian Epithelial Type Carcinoma in Testis: A Rare Testicular Neoplasm
di: Alireza Abdollahi, et al.
Pubblicazione: (2019-11-01)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
di: Martin Köbel, et al.
Pubblicazione: (2023-05-01)

Knowledge and Anxiety Related to Hereditary Ovarian Cancer in Serous Ovarian Cancer Patients
di: Sang Hee Lee, et al.
Pubblicazione: (2019-12-01)

Ovarian high-grade serous carcinoma with estrogenic manifestations in a postmenopausal woman: A case report
di: Akihiro Takeda, et al.
Pubblicazione: (2023-03-01)

Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma
di: Ashlee L. Smith, et al.
Pubblicazione: (2013-10-01)

Intra-Tumoral Lymphocytic Infiltration Is Associated with Favorable Prognosis in Suboptimal Surgery in High-Grade Serous Ovarian Carcinoma
di: Hiroshi Harada, et al.
Pubblicazione: (2025-02-01)

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
di: Takuma Ohsuga, et al.
Pubblicazione: (2017-08-01)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
di: Tsukuru Amano, et al.
Pubblicazione: (2021-01-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
di: I. S. Shponka, et al.
Pubblicazione: (2020-04-01)

Clear cell odontogenic carcinoma versus hyalinizing clear cell carcinoma: A diagnostic dilemma
di: Rama Raju Devaraju, et al.
Pubblicazione: (2014-01-01)

Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma
di: Sumei Zhang, et al.
Pubblicazione: (2023-12-01)

High-throughput approaches for precision medicine in high-grade serous ovarian cancer
di: Meinusha Govindarajan, et al.
Pubblicazione: (2020-10-01)

Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment
di: Ting Yu Chang, et al.
Pubblicazione: (2024-01-01)

High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer
di: Li Song, et al.
Pubblicazione: (2019-11-01)

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters
di: Sofia Westbom-Fremer, et al.
Pubblicazione: (2025-01-01)

Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
di: O. G. Grigoruk, et al.
Pubblicazione: (2016-09-01)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
di: Se Ik Kim, et al.
Pubblicazione: (2022-09-01)